scispace - formally typeset
J

Johanna Bertl

Researcher at Aarhus University

Publications -  18
Citations -  1959

Johanna Bertl is an academic researcher from Aarhus University. The author has contributed to research in topics: Mutation rate & Cancer. The author has an hindex of 7, co-authored 18 publications receiving 1066 citations. Previous affiliations of Johanna Bertl include Aarhus University Hospital.

Papers
More filters
Journal ArticleDOI

Pan-cancer analysis of whole genomes

Peter J. Campbell, +1332 more
- 06 Feb 2020 - 
TL;DR: The flagship paper of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium describes the generation of the integrative analyses of 2,658 whole-cancer genomes and their matching normal tissues across 38 tumour types, the structures for international data sharing and standardized analyses, and the main scientific findings from across the consortium studies.
Journal ArticleDOI

Integrative pathway enrichment analysis of multivariate omics data

Marta Paczkowska, +132 more
- 01 Jan 2020 - 
TL;DR: The authors develop ActivePathways method, which uses data fusion techniques for integrative pathway analysis of multi-omics data and candidate gene discovery that discovers significantly enriched pathways across multiple datasets using statistical data fusion.
Journal ArticleDOI

Deficiency of nucleotide excision repair is associated with mutational signature observed in cancer.

TL;DR: The results indicate that NER-deficiency increases the base substitution load twofold in liver but not in small intestinal ASCs, which coincides with the tissue-specific aging pathology observed in these mice.
Posted ContentDOI

Discovery and characterization of coding and non-coding driver mutations in more than 2,500 whole cancer genomes

Esther Rheinbay, +74 more
- 23 Dec 2017 - 
TL;DR: These analyses redefine the landscape of non-coding driver mutations in cancer genomes, confirming a few previously reported elements and raising doubts about others, while identifying novel candidate elements across 27 cancer types.